With more than 15 years of experience working in health sectors, Mr. Feander has worked with Roche to define supply chain strategies for cell and gene therapies; yielded a 15 percent reduction in cost logistics for Biogen; and worked with Sandoz to identify $300 million from moving production to low-cost countries and closing facilities.
Mr. Feander’s notable assignments include carving out and transferring $4 billion from Alcon to Novartis across 130 countries; delivering a global cost reduction program for AstraZeneca, including savings totaling 34 million euros; and identifying 20 percent savings on procurement costs for J&J.
Prior to joining A&M, Mr. Feander spent over two years with Deloitte in London, where he most recently served as Director. Previously, he served as Senior Manager with A.T. Kearney. He also held a leadership position with GE Healthcare.
Mr. Feander earned a bachelor’s degree in mechanical engineering from the University of Warwick and a master’s degree in manufacturing and management from the University of Cambridge.
